Imagen de Portada

Correction to “Functional near‐infrared spectroscopy as a biomarker of TMS efficacy in treatment‐resistant depression”

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Psychiatry and Clinical Neurosciences
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Predictive neuroimaging biomarkers of major depressive disorder treatment response: An umbrella review
por: Yasmin Esmaeilian, et al.
Publicado: (2026)

Blood‐based circRNA / miRNA biomarkers for modified electroconvulsive therapy efficacy and memory impairment in major depressive disorder
por: Shugui Gao, et al.
Publicado: (2025)

Acute and long‐term effects of repeated ketamine infusions in treatment‐resistant depression and associated metabolite changes
por: Hitoshi Sakurai, et al.
Publicado: (2025)

Abnormal choroid plexus, hippocampus, and lateral ventricles volumes as markers of treatment‐resistant major depressive disorder
por: Beatrice Bravi, et al.
Publicado: (2024)

Commentary on the article titled “Human in vivo evidence of reduced astrocyte activation and neuroinflammation in patients with treatment‐resistant depression following electroconvulsive therapy” by Xu et al.
por: Alexander A. Yakovlev
Publicado: (2024)

Habenular volume changes after venlafaxine treatment in patients with major depression
por: Josselin Etienne, et al.
Publicado: (2024)

Effects of routine repetitive transcranial magnetic stimulation on the sleep duration of patients with treatment‐resistant depression: A prospective cohort study
por: Khosro Sadeghniiat, et al.
Publicado: (2024)

Functional and structural connectivity of thalamic subnuclei in major depressive disorder at 7 Tesla
por: Weijian Liu, et al.
Publicado: (2026)

Accelerated intermittent theta burst stimulation for pharmacological treatment‐resistant bipolar depression: Protocol for double‐blind, randomized, sham‐controlled trial
por: Taro Kishi, et al.
Publicado: (2025)

Advancing posttraumatic stress disorder treatment: A novel approach in treatment‐resistant childhood sexual abuse posttraumatic stress disorder
por: Toshiaki Onitsuka
Publicado: (2024)

The longitudinal patterns of depression subtypes and stressors in depression severity in the Canadian longitudinal study on aging (CLSA)
por: Yingying Su, et al.
Publicado: (2024)

Early identification of postpartum depression using machine learning
por: Yukako Nakamura, et al.
Publicado: (2024)

Clozapine for treatment‐resistant schizophrenia with epilepsy: A case report
por: Toru Horinouchi, et al.
Publicado: (2026)

Comparison of multiple non‐invasive neuromodulation strategies for depressive episodes in major depressive disorder and bipolar disorder: A systematic review and network meta‐analysis of randomized controlled trials
por: Ping Wang, et al.
Publicado: (2025)

Plasma circulating microRNAs and symptoms of depression: Results from a population‐based study
por: Midas M. Kuilman, et al.
Publicado: (2025)

Glymphatic dysfunction as an indicator of disease burden and a potential biomarker in anti‐ NMDAR encephalitis
por: Han Cai, et al.
Publicado: (2025)

Plasma biomarkers for predicting the development of dementia in a community‐dwelling older Japanese population
por: Tomoyuki Ohara, et al.
Publicado: (2024)

Effects of particulate matter exposures on depressive symptom trajectories: Evidence from a national longitudinal survey in China
por: Hengchang Wang, et al.
Publicado: (2026)

Association of objective body shape and perceived body image with depressive symptoms in men and women
por: Seong‐Uk Baek, et al.
Publicado: (2025)

Dynamic cognitive differences between internal and external attention are associated with depressive and anxiety symptoms
por: Taiki Oka, et al.
Publicado: (2025)

Increase in luteinizing hormone is linked to reduction in depression in patients with dementia: Secondary analysis of a randomized clinical trial of benzoate
por: Chieh‐Hsin Lin, et al.
Publicado: (2025)

Altered cardiac timing neural avalanche in major depressive disorder: new insights from magnetoencephalography
por: Qian Liao, et al.
Publicado: (2025)

From relay station to circuit hub: Thalamic subnuclear precision and the major depressive disorder dysfunctome
por: Yuehua Zhao, et al.
Publicado: (2026)

Response to ‘Potential role of anti‐inflammatory cytokines in postpartum depression: Considerations for future research and improvement’
por: Chiaki T. Ono, et al.
Publicado: (2024)

Normative brain variability, clinical dimension, and molecular‐transcriptomic correlates of bipolar risk in depressed patients
por: Junneng Shao, et al.
Publicado: (2026)

Arginine vasopressin in mood disorders: A potential biomarker of disease pathology and a target for pharmacologic intervention
por: Hiroe Hu, et al.
Publicado: (2024)

Comparison of depression with anxious distress and melancholic depression from the perspective of psychomotor disturbance
por: Yu Tamada, et al.
Publicado: (2024)

The effects of potentially traumatic events on the recovery from pre‐existing anxiety and depression symptomatology and the risk of PTSD
por: Peter G. van der Velden, et al.
Publicado: (2024)

Association between the Japanese‐style diet and low prevalence of depressive symptoms: Japan Epidemiology Collaboration on Occupational Health Study
por: Haruka Miyake, et al.
Publicado: (2025)

The association between levels of brain‐derived neurotrophic factor and comorbid depression in patients with cardiovascular disease: The Framingham Heart Study
por: Sara Medved, et al.
Publicado: (2024)

Risk of subsequent Parkinson's disease among patients with bipolar disorder or major depression: A nationwide longitudinal study in Taiwan
por: Mao‐Hsuan Huang, et al.
Publicado: (2024)

Effects of childhood experiences of parental attitude, depressive rumination, and sleep disturbances on adulthood depressive symptoms
por: Shinichi Akiyama, et al.
Publicado: (2024)

White matter alterations in the corpus callosum and visual cortical regions associated with depressive and psychotic symptoms in early‐onset bipolar disorder
por: Zheng Bi, et al.
Publicado: (2026)

REIMAGINE: A central nervous system basket trial showing safety and efficacy of vafidemstat on aggression in different psychiatric disorders
por: Marc Ferrer, et al.
Publicado: (2025)

Surgical treatment may improve depressive and hysterical traits in temporal lobe epilepsy with hippocampal sclerosis: Study using the Minnesota Multiphasic Personality Inventory
por: Hiroyuki Otabe, et al.
Publicado: (2024)

Unraveling the gut‐brain connection: The association of microbiota‐linked structural brain biomarkers with behavior and mental health
por: Oren Contreras‐Rodriguez, et al.
Publicado: (2024)

Acute prefrontal hemodynamic responses to intermittent theta burst stimulation correlate with current depression and episode recurrence: A cross‐sectional study
por: Minxia Jin, et al.
Publicado: (2026)

Improvement in avoidance in major depressive disorder: A 10‐month prospective study of depressive symptoms and personality traits
por: Ryotaro Higuchi, et al.
Publicado: (2026)

Integrative methylation and miRNA dysregulation in dlPFC reveal distinct molecular signatures of suicide and non‐suicide subtypes in major depressive disorder
por: Aleena Francis, et al.
Publicado: (2026)

Examining the feasibility and limitations of AST‐001 as a treatment for autism spectrum disorder
por: Chenxi Wang, et al.
Publicado: (2024)